Equity
Intuitive Surgical·Balance Sheet Statement·9 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities and stockholders' equity | $16.6B | $17.7B | $18.7B | $19.2B | $20.2B | $19.4B | $20.5B | $20.1B |
| Total stockholders' equity | $14.7B | $15.6B | $16.4B | $17.1B | $17.8B | $16.9B | $17.8B | $17.5B |
| Additional paid-in capital | $9.1B | $9.4B | $9.7B | $10B | $10.2B | $10.5B | $10.8B | $11.1B |
| Retained earnings | $5.6B | $6.1B | $6.8B | $7.1B | $7.6B | $6.4B | $7B | $6.4B |
| Investments - Gross Unrealized Losses | $3.2B | $1.9B | $3.4B | $2.1B | $2B | $1.2B | $609.7M | $2.3B |
| Accumulated other comprehensive income (loss) | -$23.5M | $12.9M | -$51.3M | -$27.1M | $3M | $26.5M | $43.3M | $16.5M |
| AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss | $28.5M | $13.2M | $9.2M | $6M | $4.3M | $3.7M | $1.4M | $900K |
| Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | $400K | $400K | $400K | $400K | $400K | $400K | $400K | $400K |
| Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |